Modulated Mid-frequency Whole-body Electromyostimulation and Nutritional Therapy in Gastrointestinal Cancer Patients

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Cologne

About this trial

The purpose of this study is to assess the efficacy of modulated mid-frequency whole-body electromyostimulation (WB-EMS) combined with nutritional therapy in patients with gastrointestinal cancer.

Eligibility criteria

Qualifiers

Patients with oesophageal, gastric, duodenal, colon or rectal cancer following surgery without further therapy and with neoadjuvant and adjuvant therapy

medical clearance for exercise training

written declaration of consent from the study participant

Disqualifiers

Participation in another study on the topic of exercise or nutrition

Electronic implants such as pacemakers, pumps, and coronary stents

Cardiac arrhythmia

Implants in the area of application (e.g. breast implants)

Trial design

Treatments tested in this trial

  • mid-frequency whole-body electromyostimulation (WB-EMS)
  • conventional exercise training
  • nutritional therapy

Treatment groups

88 Participants
are divided into 2 treatment groups

Sponsors and collaborators